IGHE and allergic disease: But the effect of omalizumab is also evident locally in target organs of allergy such as the lung: Diminished levels of CD3, CD4, CD8 lymphocytes as well as reduced staining for IgE and IL-4 were observed in the submucosa of bronchial biopsies of omalizumab-treated patients (122).